[The comparative characteristics of parlodel, zinc sulfate and recombinant erythropoietin in treating uremic hypogonadism in patients on chronic hemodialysis].
Kukhtevich
A V
AV
Ermolenko
V M
VM
Dedov
I I
II
Gitel'
E P
EP
Buniatian
A F
AF
Smirnova
G A
GA
D000328:Adult; D001971:Bromocriptine / Q000627:therapeutic use*; D002908:Chronic Disease; D004341:Drug Evaluation; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D007006:Hypogonadism / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D007676:Kidney Failure, Chronic / Q000097:blood / Q000150:complications / Q000628:therapy; D008297:Male; D008875:Middle Aged; D010410:Penile Erection / Q000187:drug effects; D011994:Recombinant Proteins / Q000627:therapeutic use; D006435:Renal Dialysis / Q000009:adverse effects*; D013091:Spermatogenesis / Q000187:drug effects; D013431:Sulfates / Q000627:therapeutic use*; D014511:Uremia / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D015032:Zinc / Q000627:therapeutic use*; D019287:Zinc Sulfate
D011994:Recombinant Proteins; D013431:Sulfates; D004921:Erythropoietin; D001971:Bromocriptine; D019287:Zinc Sulfate; D015032:Zinc
Sravnitel'naia kharakteristika parlodela, tsinka sul'fata i rekombinantnogo éritropoétina v lechenii uremicheskogo gipogonadizma u bol'nykh, nakhodiashchikhsia na khronicheskom gemodialize.